GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 18 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $167,000 | +46.5% | 18,314 | 0.0% | 0.14% | +109.1% |
| Q2 2017 | $114,000 | +12.9% | 18,314 | -36.1% | 0.07% | +127.6% |
| Q4 2016 | $101,000 | -28.9% | 28,679 | -10.4% | 0.03% | -3.3% |
| Q3 2016 | $142,000 | -1.4% | 31,990 | 0.0% | 0.03% | -16.7% |
| Q2 2016 | $144,000 | -8.9% | 31,990 | 0.0% | 0.04% | -26.5% |
| Q1 2016 | $158,000 | +11.3% | 31,990 | +71.2% | 0.05% | +32.4% |
| Q4 2015 | $142,000 | -48.9% | 18,690 | -50.0% | 0.04% | -50.0% |
| Q3 2015 | $278,000 | -26.1% | 37,380 | 0.0% | 0.07% | +4.2% |
| Q2 2015 | $376,000 | +6.8% | 37,380 | 0.0% | 0.07% | +14.5% |
| Q1 2015 | $352,000 | +62.2% | 37,380 | 0.0% | 0.06% | +77.1% |
| Q4 2014 | $217,000 | -32.4% | 37,380 | 0.0% | 0.04% | -14.6% |
| Q3 2014 | $321,000 | -36.3% | 37,380 | -27.8% | 0.04% | -22.6% |
| Q2 2014 | $504,000 | +69.7% | 51,766 | +100.0% | 0.05% | +55.9% |
| Q1 2014 | $297,000 | – | 25,886 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |